Top Stories News
Top Stories news
-
News Exciting new vaccine targets killer disease TB
Australian researchers produce early-stage vaccine which is inhaled into the lungs. -
News Switzerland overtakes Germany as Europe’s biggest drug delivery innovator
Pipeline of new drugs has helped drive increased innovation in packaging and drug delivery devices. -
News How real-world data can revolutionise drug development
Utilising the current data environment and its data pools for the benefit of advancing research. -
News Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings
The benefits of this innovation include the ability to instantly and unequivocally authenticate products when suspect events. -
News Mylan and Pfizer create new global pharma company
The transaction will allow the new company to expand the geographic reach of Mylan's existing broad product portfolio and future pipeline. -
News GSK opens new continuous manufacturing facilities in Singapore
Opening of continuous manufacturing facilities and expansion of production building will boost capabilities to accelerate the supply of new breakthrough medicines to patients globally. -
News Catalent extends global commercial spray drying capabilities in Europe
Company's customers to have immediate access to Niro PSD2 and PSD4 spray driers, which are supported by dedicated clean area facilities for both solvent and aqueous processing of potent or non-potent drug formulations. -
News Inaugural Bio Integrates conference highlights industry's inefficiency in developing products
Industry leaders give voice to issues and trends shaping the biotech sector, including the importance of collaboration. -
News Lessons learned from early EU FMD adopters
Data exchange, investment costs, resources and hardware identified as some of the biggest challenges. -
News Brexit's trick or treat on patient safety
Despite a delayed Brexit, unpredictability adds further complications to the EU FMD regulation. -
News Surge of Indian biosimilars market forecast in 2019
India predicted to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production. -
News RAPS on delayed Brexit
The post-Brexit regulatory environment continues to weigh heavily on the minds of regulatory professionals. -
News Sizeable growth potential for global drug delivery and packaging in 2019
Patient-centricity, eco-friendly and smart packaging trends marked as the biggest growth drivers and innovations in 2019. -
News Injecting innovation into micro-injection molded solutions
End-to-end industrial production of innovative medical technology products. -
News 'Tamper-evident' benefits are evident
2019 will mark Uniplast's debut at this year's edition of CPHI Worlwide in Frankfurt, where it will showcase its expertise in plastic packaging. -
News All Recipharm facilities ready for EU serialisation, regardless of Brexit
The CDMO invested EUR 35 million into its operations and launched a 3-year programme to provide a compliant serialisation solution for its customers. -
News Brexit - the EU FMD's painful problem
Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic. -
News Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering
New report highlights Germany, France and Switzerland as tier-one nations for ‘drug delivery innovation’, and warns the challenge will be to scale-up and approve promising prototypes. -
News New API screening program strengthens Particle Sciences' nanomilling offering
Advanced formulation techniques such as nanomilling may provide an excellent route to improved bioavailability and enhanced therapeutic effect. -
News Univercells introduces breakthrough vaccine manufacturing platform
The automated NevoLine bioproduction system that facilitates safer, faster and closed bioprocessing in a much smaller footprint. -
News BMS and Celgene merge to create premier innovative biopharma company
Significantly expands Phase III assets with six expected near-term product launches, representing greater than $15 billion in revenue potential. -
News An increased risk of a hard or ‘no deal Brexit?
A ‘no deal’ Brexit will change and burden how all industries that move materials and goods across borders, including the pharmaceutical and medical device sectors, do business. -
News One month on: medical cannabis is still taboo despite change in law
Restrictive guidelines have led many to buy CBD products online, leading to a boom in production with many products going to market without sufficient quality control. -
News EU FMD - time is running out!
Companies that have left it too late to implement their own solution will have to rely on support from providers, whose resources are already in high demand as the deadline approaches. -
News Proprietary nasal delivery formulation of diazepam reaches NDA
The absolute bioavailability of the Valtoco intranasal formulation was 96% of intravenous diazepam in a Phase I cross-over trial. -
News DSCSA one-month countdown!
With only a month to go, it really is too late to start trying to develop an in-house solution. -
News Global pharma set for strong year
Eight of the top ten pharma nations reporting improving market conditions. -
News Generics companies to move away from "little white pills"
Accepting more complexity and risk is key for those generics companies seeking competitive differentiation by diversifying their product portfolios. -
News CMOs to benefit from double digit approvals for ADCs in the next 3 years
Therapeutic ADC market expected to reach $4 billion by 2023. -
News Movement on the market reflected at CPHI Worldwide 2018
Companies new to CPHI to showcase an exciting range of products and services ranging from electroceuticals to refrigerant alternatives. -
News Moulds & Tooling: A European success story
While not quite an endangered species, the past fifteen years have not been easy ones for many European mould makers. Many, but not all, and IGS GeboJagema is a case in point – a case that shows the difference automation and focus can make. By Karen La... -
News Sanofi to refocus two global business units
The new Primary Care and China & Emerging Markets global business units are expected to launch at the beginning of 2019. -
News Experts warn trade and patent changes could increase healthcare cost by $100bn over next 5 years
China is harmonizing to ICH standards at feverish pace and will force poor quality manufacturers out of market. -
News Exciting skincare to protect against blue light emitted by phones and devices
Novel, dual-acting product revitalizes and protects skin against blue light and environmental aggressors around the clock. -
News Bio processing and manufacturing league table ranks US top and China bottom
US, Germany and Japan revealed as tier one nations in all categories with Sweden ranking the best of the rest. -
News Innovation "hindered by regulators"
CPHI Annual Report expert sees CDMOs as potentially a source of process innovation but warns both regulator and license holders need to move past regulatory diktats. -
News The 6-month FMD countdown - are you ready?
With only 6 months left in which to become EU FMD-compliant, how can companies make the best use of their now limited options? -
News Protecting the links between the UK and the EMA
Now less than a year away from when the UK officially leaves the EU, the main goal remains the same - maintaining access to new drugs for patient health. -
News Building contingency plans for an ambiguous post-Brexit market
One company's positive approach to Brexit preparations, despite the lack of definition. -
News Post-Brexit medicines - stuck in the UK?
The EMA needs to provide more action and guidance to help UK pharmaceutical manufacturers, says Thomas Beck, senior vice president, quality management, Recipharm. -
News Pharmacovigilance post-Brexit - simpler than previously thought?
To meet new PV regulations, the industry has to face a "multitude of unknowns and an ever-moving target". -
News South Korea's finished drug market growth driven by generics
FDF launches at CPHI Korea as country set to become regional hub. -
News Bosch to sell its packaging business
Packaging technology is not a core Bosch business. -
News Ingredients to improve bioprocess manufacturing efficiency
Experts warn bio industry needs to do more to create a sustainable pipeline of talent. -
News Internationalisation and regulatory reform driving growth and investment at CPHI China
2018 event prepares for surge in international attendees as MAH nears national rollout. -
News Investing in blistering capabilities to boost flexibility
Postponement printing is presenting interesting benefits for the pharmaceutical supply chain. -
News Serialisation — looking for value-added opportunities
Recipharm's Staffan Widengren, Director Corporate Projects, discusses why CMOs should be focusing on the value-added opportunities presented by serialisation. -
News Industry’s largest survey on serialization readiness throws up disparity
Global Drug Supply, Safety and Traceability Report reveals disparity in industry’s readiness to comply with track and trace regulations in the US and EU. -
News Omega-3s from fish oil supplements no better than placebo for dry eye
NIH-funded study finds omega-3 fails to yield beneficial results in the clinic. -
News bioLIVE to introduce global biopharma country ranking
Global analysis will rank each major biomanufacturing country’s market growth potential, innovation and competitiveness. -
News Technology and managing risk within the high potency drug sector
Manufacturing high potency drugs - the challenges and innovations to mitigate the risks. -
News TraceLink grows market position in DACH region by 215%
Customers cite network connectivity, efficiency of partner onboarding, and seamless data exchange as significant differentiators. -
News Lonza expands encapsulation and HPAPI capabilities in North America
Customers to have the option of one partner from concept to market for their encapsulated drug products -
News Company goes all out to fully support clients
Gaining GLP/GMP accreditation to provide greater assurance of data integrity for clients looking to take their compounds to IND. -
News Acquisition taps into the unknown treasures of the sea
Screening for new marine-derived functional ingredients and bringing new patented products to the market. -
News Patient centricity and innovation a winning formula at packaging awards
Packaging innovation shows a clear focus on patient compliance and ease-of-use. -
News Best practice tips for selecting a prepared media supplier
What does a good supplier look like? Andrew Ramage, Microbiology Product Specialist at Cherwell Laboratories, advises how to take the guesswork out of the search. -
News A powerful new tool for the separation of charged species
A new analytical tool, Electrical Asymmetrical Flow Field-Flow Fractionation (EAF4) is showing much promise in biopharmaceutical and nanoparticle applications. -
News 2017: A year of innovation and advances
A summary and highlights of new drug therapy approvals and other drug therapy advances in 2017 by FDA's CDER. -
News Teva to axe 25% of its total workforce
Total cost base to be reduced by $3 billion by the end of 2019. -
News Major breakthrough for new haemophilia A treatment
Drug trials provide mind-blowing results. -
News Major pharma company to make significant investment in the UK
MSD's announcement to establish UK Discovery Centre in London an 'endorsement' of the government's Industry Strategy. -
News Key trends in formulation development for 2018
Controlled-release technologies will continue to be focal point, whereas techniques to improve solubility are likely to gain popularity. -
News Recipharm to end operations in two facilities in Sweden
Company's decision affects approximately 225 staff, specialised in tablet manufacturing, and in sachet and stick pack filling, primarily for powders and granules. -
News CPHI Worldwide announces the winners for its 14th Pharma awards
19 winners chosen from 200 entries, received from nearly 30 countries worldwide. -
News Will Novo Nordisk's semaglutide be its next blockbuster?
Semaglutide receives positive 16-0 vote in favour of approval from FDA Advisory Committee. -
News Boosting capabilities through collaboration
CDMO, Micro-Sphere partners with German machine manufacturer Harro Höfliger for the latest step in its 21 million CHF (€19 million) investment into its facility in Switzerland. -
News Highly potent APIs - can your CMO handle them?
The importance of ensuring a facility has the right capabilities when selecting a CMO to handle high potency ingredients. -
News FDA warns Pfizer company about cGMP violations associated with the manufacture of EpiPen
Warning letter cites Meridian Medical Technologies' failure to thoroughly investigate multiple serious component and product failures of EpiPen products. -
News Novo Nordisk settles US federal investigation of marketing practices
In connection with the $60 million settlement, the company has also resolved several private whistle-blower cases related to the government's investigation. -
News Mylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector
Mylan will reclassify EpiPen Auto-Injector for purposes of the Medicaid Drug Rebate Program and pay the rebate applicable to innovator products effective as of 1 April 2017. -
News Lonza acquires Micro-Macinazione to create the leader in micronization capacity and capabilities
Bolt-on acquisition adds value to other areas of Lonza’ business, including Health & Nutrition ingredients and excipients. -
News Artificial intelligence to discover drugs in a multi-year multimillion dollar deal
AI thought to have massive potential to reduce the cost associated with the discovery of new drugs. -
News Merck and Pfizer collaborate with Corning to modernize pharmaceutical glass packaging
Collaborations result in development of Corning Valor Glass. -
News GSK delivers double-edged sword
Company announces investments, the sale of several products and a proposal to close a UK manufacturing site. -
News Researchers develop microneedle patch for flu vaccination
The patch can dramatically reduce the cost of vaccination, as self-administration can eliminate the need to have health workers oversee the process. -
News Takeda terminates plans for Vaxem Hib launch in Japan
Discontinuation due to the vaccine supplier’s (GSK) decision to discontinue global production. -
News Croda celebrates EXCiPACT Certification across all leading excipient sites
Status marks the company as the first multi-site excipient supplier to achieve global EXCiPACT accreditation across its production facilities. -
News Chemotherapy as a tablet instead of an intravenous infusion
New production method for solid dispersions of docetaxel and paclitaxel. -
News Landmark outcomes study shows that Repatha decreases LDL-C to unprecedented low levels
Amgen has announced that the 27,564-patient Repatha (evolocumab) cardiovascular outcomes study, FOURIER, established for the first time that maximally reducing low-density lipoprotein cholesterol (LDL-C) levels with Repatha, beyond what is possible wit... -
News Mylan announces global settlement and license Agreements with Genentech and Roche on Herceptin
Settlement provides Mylan with global licenses for its trastuzumab product. -
News Pharma's most innovative companies; the 2017 ranking
Innovation is being driven increasingly by smaller, possibly more agile, companies. -
News Can yeast rise to the challenge of curing cancer?
Modified baker’s yeasts cause an immune response and the production of lymphocyte killers, which detect and eliminate cancerous cells. -
News Turbofer: innovative formulation for iron deficiency
NTC Pharma expands its product portfolio with a new food supplement containing iron pyrophosphate microencapsulated in liposomal form, Turbofer orosoluble granules. -
News Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic
The molecule, which is a PPMO, will likely be ready for testing in humans in about 3 years. -
News Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease
Therapies targeted at this novel mechanism have the potential for disease-modification because they will address the genetic root cause of AD. -
News Ariad to be acquired by Takeda for $5.2 billion
Ariad stockholders to receive $24.00 per share in cash. -
News Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic
Authorized generic offered at more than 50% below wholesale acquisition cost of EpiPen auto-injector. -
News Lonza to acquire Capsugel
Acquisition will make Lonza a fully integrated solutions provider in oral delivery technologies and active ingredients to the consumer healthcare and nutrition markets. -
News BMS strengthens capabilities with evolution of its US geographic footprint
Company will also close its Hopewell, New Jersey site and will not renew its lease at the Lake Union Steam Plant site in Seattle, Washington. -
News Pfizer refutes the findings set out in the CMA decision
Pharma giant says it complied with established competition law. -
News Hopes dashed for new Alzheimer drug
Lilly's solanezumab fails to meet primary endpoint of Phase III study. -
News Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor
Bococizumab deemed unlikely to provide value to patients, physicians, or shareholders. -
News Fighting cancer with the power of immunity
New treatment elicits two-pronged immune response that destroys tumors in mice. -
News Pfizer announces US availability of biosimilar Inflectra
Inflectra will be the first biosimilar monoclonal antibody (mAb) to be available in the US. -
News Mylan agrees to settlement on Medicaid Rebate Classification for EpiPen Auto-Injector
The terms of the settlement do not provide for any finding of wrongdoing on the part of Mylan Inc. or any of its affiliated entities or personnel. -
News Pfizer decides to remain as one company
Company to continue to operate as one company with two distinct and complementary businesses to retain operating strength and financial flexibility. -
News Leading pharmaceutical companies present industry roadmap to combat antimicrobial resistance
Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance. -
News GSK announces significant new investment in UK manufacturing network
Investment in advanced manufacturing of new respiratory and biopharmaceuticals portfolio. -
News BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer
This milestone marks the sixth Breakthrough Therapy Designation for Opdivo. -
News Shire completes combination with Baxalta
Combined company expected to deliver double-digit compound annual top-line growth with over $20 billion in annual revenues by 2020. -
News Valeant names Joseph C. Papa to be Chairman and CEO of Valeant Pharmaceuticals
Brings more than three decades of leadership and operations experience in healthcare. -
News Pfizer–Allergan merger agreement terminated
Allergan reiterates strong standalone growth profile and strategy following termination of Pfizer transaction. -
News Engineers develop a pill for long-term drug release
New tablet attaches to the lining of the GI tract, resists being pulled away. -
News Sir Andrew Witty to retire from GSK in March 2017
The Board will now conduct a formal search for a successor and will consider internal and external candidates for the role. -
News CMA fines pharma companies £45 million
The CMA has fined a number of pharmaceutical companies for anti-competitive conduct and agreements in relation to the supply of paroxetine. -
News Shire to combine with Baxalta, creating the global leader in rare diseases
Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020. -
News UBM celebrates securing more than 36000 attendees at biggest ever CPHI Worldwide
World’s largest pharma event sees record exhibitor numbers in Madrid. -
News Pfizer and Allergan to combine
As a result of the combination with Allergan and subsequent integration of the two companies, Pfizer now expects to make a decision about a potential separation of the combined company's innovative and established businesses by no later than the end of... -
News BMS to sell its HIV R&D portfolio to ViiV Healthcare
Transactions are consistent with the evolution of BMS’s strategic focus, including the decision to discontinue its discovery efforts in virology announced in June. -
News Catalent working to re-start production at French facility
Company’s preliminary investigation indicates tha the incidents of out-of-place softgel capsules in several product batches could be related to a deliberate action by one or more individuals. -
News Perrigo shareholders convincingly reject Mylan's tender offer, expressing confidence in Perrigo's long-term strategy
Perrigo will immediately commence its previously announced $2 billion repurchase of Perrigo shares and plans to complete $500 million of the planned repurchase by the end of 2015. -
News Roche to restructure its manufacturing network for small molecules
Exiting four sites to optimise capacity utilisation will affect approximately 1,200 positions. -
News Sanofi Pasteur reveals its research on a ”universal” influenza vaccine
The vaccines division of Sanofi presents at the World Vaccine Congress in Spain. -
News Eli Lilly announces expansion of Indianapolis R&D headquarters
New building to feature collaboration-focused workspace. -
News Biogen Q3 2015 revenues increase 11% to $2.8 billion
Corporate restructuring to result in an 11% workforce reduction. -
News Lilly to discontinue development of evacetrapib for high-risk atherosclerotic cardiovascular disease
Phase III trial terminated due to insufficient efficacy. -
News NIH grantees win 2015 Nobel Prize in chemistry
Prize awarded for mapping, at a molecular level, how cells repair damaged DNA and safeguard the genetic information. -
News FTC files amicus brief explaining that pharmaceutical “product hopping” can violate the antitrust laws
The FTC filed its amicus brief in a private antitrust action in which Mylan Phamraceuticals Inc. alleges that Warner Chilcott PLC/Mayne Pharma Group maintained a monopoly in the market for its antibiotic Doryx by suppressing generic competition through... -
News National Biologics Manufacturing Centre launched
The new centre will provide companies with open access facilities and expertise to help them develop, prove and commercialise new and improved processes and technologies for biologics manufacture.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance